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ABSTRACT 
Background: Adults with long term neurological conditions can face complex challenges 
including anxiety and depression. Emerging research suggests the utility of third wave 
approaches (the third development of psychotherapies) in working transdiagnostically with 
these difficulties. Aims: This systematic review sought to summarise and appraise the quality 
of published empirical studies using third wave therapies such as: Compassion Focused 
Therapy (CFT); Acceptance and Commitment Therapy (ACT); and Mindfulness-Based 
Cognitive Therapy (MBCT) or Mindfulness-Based Stress Reduction (MBSR). Method: 
Review procedures followed PRISMA guidelines, with 437 abstracts screened, 24 full-text 
articles retrieved and 19 studies found to meet inclusion criteria. Six out of seven randomised 
studies had unclear or high risk of bias, whilst the majority of non-randomised studies were 
considered moderate quality. Results: Overall, studies reported a statistically significant 
reduction in emotional distress. Of the 13 studies that used model-specific process measures, 
10 found statistically significant improvements in transdiagnostic factors. Discussion: The 
findings indicate that third wave therapies show promise in addressing transdiagnostic 
difficulties within neurological conditions. A number of methodological and conceptual 
issues for the included studies were highlighted during the quality appraisal process. Clinical 
implications include consideration of intervention length and use of outcome measures. 
Research implications are discussed by considering the progressive stages of development for 
behavioural treatments. 
 
Key words; third wave therapies; Acceptance and Commitment Therapy; Mindfulness; 
transdiagnostic; neurological condition; systematic review 
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INTRODUCTION 
According to the National Service Framework (NSF) in the United Kingdom (Department of 
Health (DoH), 2005), a long term neurological condition results from disease, injury or 
damage to the body’s nervous system (the brain, spinal cord and/or their peripheral nerve 
connections), which will significantly impact on the individual and their family for the rest of 
their life. This includes progressive conditions such as Multiple Sclerosis (MS), Parkinson’s 
Disease and Motor Neurone Disease (MND); sudden onset conditions such as spinal cord 
injury, Acquired Brain Injury (ABIs) including stroke and Traumatic Brain Injury (TBIs); 
and intermittent conditions such as epilepsy (DoH, 2005). While stroke is covered by the 
NSF for older people (DoH, 2001), for the purposes of this review it is included here as a 
long term neurological condition. 
 
It is estimated that ten million people are affected by long term neurological conditions in the 
UK (DoH, 2005). Such individuals often face complex challenges in daily living, including 
physical, emotional, psychological and social difficulties. Higher levels of anxiety and 
depression as compared to people in good physical health have been reported, with estimates 
of both being approximately two to three times more common in long term neurological 
conditions (Bombardier et al., 2010; Hackett, Yapa, Parag & Anderson, 2005; Kangas, Tate, 
Williams & Smee, 2012; Reijnders, Ehrt, Weber, Aarsland & Leentjens, 2008; Whelan-
Goodman, Ponsford & Schönberger, 2009).  Individuals are reportedly also more likely to 
experience significant difficulties with adjustment, self-image, and identity (Ellis-Hill & 
Horn, 2000; Gracey, Evans & Malley, 2009; Gracey & Ownsworth, 2008; Roger et al., 
2014). In their service delivery guidance, the NSF advocates psychological support to enable 
individuals to achieve a sense of wellbeing and adjust to altered personal, family and social 
circumstances.  Equally, a biopsychosocial approach is advocated for within the International 
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Classification of Functioning, Disability and Health (ICF, World Health Organisation 2001). 
This guidance highlights that adjustment to changes in functioning and lifestyle as being 
influenced by a range of personal and environmental factors and suggests a role for 
psychological approaches. 
 
Psychological therapy for neurological conditions 
The psychological difficulties associated with long term neurological conditions have 
conventionally been addressed by transferring evidence-based therapies from mainstream 
practice, with Cognitive Behavioural Therapy (CBT) being most evidence-based (Fernie, 
Kollman, & Brown, 2015). Systematic reviews exist that demonstrate the efficacy of CBT for 
depression in specific neurological conditions such as MS (Hind et al., 2014), epilepsy (Fiest 
et al., 2013); and TBI (Fann, Hart & Schomer, 2009; Gertler, Tate & Cameron, 2015); CBT 
for anxiety in TBI (Soo & Tate, 2007); and CBT for depression and anxiety in ABI (Waldron, 
Casserly & O’Sullivan, 2013). On one hand, there is evidence to suggest better outcomes and 
effect sizes are obtained for disorder specific CBT approaches in ABI (Waldron et al., 2013), 
although there was a lack of available intervention studies using a transdiagnostic approach at 
the time to be included in their review.  
 
On the other hand, the heterogeneity of neurological diagnoses means clinicians and 
researchers can be working with individuals whose emotional needs do not meet specific 
diagnostic criteria and present as co-morbidities (Gracey et al., 2015). Emotional distress in 
particular can present as a range of emotional and neurobehavioural reactions (Shields, 
Ownsworth, O’Donovan & Fleming, 2016). Such difficulties could benefit from a 
transdiagnostic rather than disorder-specific approach (Gracey et al., 2015). Until the 
systematic review by Fernie and colleagues (2015), no prior reviews were found that assessed 
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CBT in neurological conditions as a category. This is relevant, as many neurological 
conditions share impairment characteristics such as executive dysfunction and limited 
mobility (Fernie et al., 2015), as well as psychological factors such as changes in self-concept 
(Roger, Wetzel, Hutchinson, Packer, & Versnel, 2014). Therefore, assessing interventions for 
neurological conditions as a category may help the results of a review become more 
generalisable and useful in its clinical and research implications (Fernie et al., 2015).  
 
Transdiagnostic processes 
While there are clear differences and variations between long term neurological conditions, 
such as their aetiology, epidemiology and prognosis, there are also similarities in terms of 
common psychological processes across diagnoses. In setting out to consider transdiagnostic 
processes and treatment approaches, it seems important to highlight the conceptual confusion 
within the literature that has led to the terms transdiagnostic process and approach often being 
used interchangeably. For the purpose of this review, a transdiagnostic process refers to the 
psychological processes that can occur across a range of disorders, such as rumination. It has 
been defined as “an aspect of cognition or behaviour that may contribute to the maintenance 
of a psychological disorder” (Harvey, Watkins, Mansell, & Shafran, 2004, p. 14). 
Meanwhile, a transdiagnostic approach refers to a treatment approach that focuses on what 
disorders have in common. For example, a mindfulness-based therapy can be used with a 
range of disorders. By using a transdiagnostic approach, clinicians can target the functional 
underpinnings of multiple psychological problems rather than being driven by a disorder-
specific approach. 
 
An up-to-date review by Salkovskis et al. (2016) has discussed the utility of a CBT-grounded 
transdiagnostic approach to working therapeutically with long term conditions generally. The 
5 
 
paper highlights transdiagnostic factors important to consider including: mood changes, 
attentional processes, emotional avoidance/suppression, safety-seeking behaviours, all-or-
nothing (“boom or bust”) behaviour, generalised withdrawal, rumination, autonomic arousal, 
sleep disturbances, and the potential for deconditioning in some diagnoses. Meanwhile, 
Shields et al. (2016) have recently completed a transdiagnostic investigation of emotional 
distress after TBI. They synthesised findings from across studies and identified a number of 
transdiagnostic processes, such as repetitive negative thinking including rumination and 
worry, avoidance behaviours, threat appraisals, negative self-concept and self-discrepancy, 
difficulties with emotion regulation and negative self-focussed attention. These 
transdiagnostic processes are by no means unique to TBI. For example, there is research to 
suggest the relevance of self-concept and self-discrepancy in stroke and ABI (Ellis-Hill & 
Horn, 2000; Ownsworth & Gracey, 2010; Shields & Ownsworth, 2013) and neurological 
conditions generally (Roger et al., 2014); and threat appraisals in progressive disorders such 
as MS (Dennison, Moss-Morris, & Chalder, 2009). Furthermore, Versnel and colleagues 
(2013) discuss the commonality of “illness experience” across neurological conditions, and 
assert that these experiences are not diagnostic-specific. The authors therefore set out to 
examine the transdiagnostic impact of neurological conditions on everyday life. From the 
similarities of the current literature, it seems important to consider transdiagnostic processes, 
and thus transdiagnostic treatment approaches, across long term neurological conditions. 
 
Third wave therapies 
There have been several developments within therapies that have promoted a shift away from 
altering psychological events such as thoughts, beliefs and cognitive schemas, towards 
therapies that aim to change the individual’s relationship to their psychological experiences 
(Hayes, 2004). These “third wave therapies” are so-called because they form the third 
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development of psychotherapy and represent an extension of CBT (Hayes, 2004). Third wave 
therapies including Acceptance and Commitment Therapy (ACT; Hayes, Strosahl, & Wilson, 
1999), Compassion Focused Therapy or Compassionate Mind Training (CFT/CMT; Gilbert, 
2009) and Mindfulness-Based Stress Reduction or Mindfulness Based Cognitive Therapy 
(MBSR/MBCT; Kabat-Zinn, 1990), amongst others (Dialectical Behavioural Therapy: 
Linehan, 1993; Metacognitive Therapy: Wells, 2000). These therapies are considered 
transdiagnostic approaches as they transcend diagnostic categories, as outlined by Craske 
(2012). Transdiagnostic processes such as difficulties with emotion regulation are key skills 
addressed using therapies such as ACT, DBT and CFT, which aim to reduce unhelpful and 
avoidant coping and encourage use of adaptive emotion regulation skills such as reappraisal, 
self-soothing and mindfulness (Shields et al., 2016). 
 
Acceptance-based approaches 
ACT is theoretically rooted in Relational Frame Theory (Hayes, Barnes-Holmes, & Roche, 
2001), a contextual behavioural approach to human language and cognition. Psychological 
flexibility is the applied model that underlies an ACT approach and refers to the ability to 
more fully contact the present moment, and the thoughts and feelings it contains, to change or 
persist with behaviours that serve personal values (Hayes, Villatte, Levin, & Hildebrandt, 
2011). The approach is organised around six processes: defusion, acceptance, present 
moment focus, self-as-context, values, and committed action. The principles of ACT are 
taught to clients by means of experiential exercises, mindfulness methods, and a specific use 
of language (e.g. metaphors and paradoxes).  
 
The application of ACT has been explored in neurological populations in several recent 
papers. Firstly, the role of pain acceptance in adjustment to chronic pain secondary to 
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neurological disorders has been reviewed (Kratz, Hirsh, Ehde, & Jensen, 2013), with chronic 
pain associated with MS in particular being targeted (Tooze, Karl, Dysch, & McLaughlin, 
2014; Carrigan & Dysch, 2015). Acceptance approaches have also been evaluated in the 
positive adjustment to changed life circumstances as a result of conditions including MS 
(Pakenham & Fleming, 2011), ABIs (Sylvester, 2012) and in chronic health conditions more 
generally.  While it has been found that an ACT approach can be helpful in managing anxiety 
generally, it is yet to be specifically reviewed for managing anxiety in ABIs (Soo, Tate, & 
Lane-Brown, 2011). Within the TBI literature, a recent conceptual review has indicated that 
therapies which promote psychological flexibility (such as ACT) are beneficial to people with 
TBI who have damage to areas controlling executive functioning (Whiting, Deane, Simpson, 
McLeod & Ciarrochi, 2017). 
 
Compassion-based approaches 
Gilbert’s (2009) model of CFT uses theory from social, developmental, evolutionary and 
Buddhist psychology, and neuroscience to apply a compassion model to psychotherapy. 
Drawing on this model, CMT refers to specific activities designed to develop compassionate 
attributes and skills, principally those that influence affect regulation (Gilbert, 2009). It was 
developed for clients who experience high levels of shame and self-criticism, to teach them 
how to self-soothe (Gilbert & Proctor, 2006).  Ashworth, Gracey, and Gilbert (2011) have 
illustrated the feasibility of CFT in working with the shame experienced by an individual 
following ABI and found significant reductions in anxiety and depression and significant 
increases in kindness and self-warmth. It must be noted that the research by Ashworth et al. 
(2011) was conducted within the context of a highly intensive and comprehensive 
rehabilitation programme and this would likely have some implications in terms of 
generalisability.  
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Mindfulness-based approaches 
Jon Kabat-Zinn (1994) defines Mindfulness as: “paying attention in a particular way: on 
purpose, in the present moment, and nonjudgmentally” (p.4). Mindfulness practices originate 
from ancient Buddhist meditation techniques but have been adapted for clinical settings. The 
best researched of these approaches is MBSR. MBSR was developed by Jon Kabat-Zinn in 
1979 for people with chronic pain and terminal health conditions that were initially difficult 
to treat in a hospital setting. MBSR consists of breath awareness, body awareness and 
mindful movement, taught in a group over eight weeks. MBCT is a derivative that places 
greater emphasis on cognitive techniques and was designed with recurrent depression in 
mind. There is also growing evidence of the use of mindfulness-based interventions in 
neurological populations to: enhance wellbeing and quality of life in individuals with MS 
(Senders, Bourdette, Hanes, Yadav, & Shinto, 2014) and brain injury (Azulay, Smart, Mott & 
Cicerone, 2013; Bédard et al., 2003; 2005); reduce depressive (Grossman et al., 2010) and 
anxiety symptoms (Hankin, 2010) in MS; improve fatigue in stroke (Johnanssen, Bjuhr, & 
Rönnbäck., 2012) and ABI (Johanssen Bjuhr, & Rönnbäck, 2013); improve symptom 
management in MS (Mills & Allen, 2000); and to address cognitive deficits (McHugh & 
Wood, 2013). 
 
Why is it important to undertake a review? 
The number of papers being published that evaluate the use of third wave therapies is 
increasing each year. A pilot literature search of third wave therapies and neurological 
conditions in August 2014 found 18 papers, with the earliest publication date being 2003. 
Twelve of the 18 papers have been published since 2011. To the author’s knowledge, the 
literature reviews undertaken to date have related to specific third wave therapies for specific 
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neurological conditions, such as ACT for ABI (Kangas & McDonald, 2011), ACT for anxiety 
in ABI (Soo, et al., 2011), and mindfulness-based approaches for MS (Simpson et al., 2014) 
or stroke (Lawrence, Booth, Mercer, & Crawford, 2013). The range of difficulties associated 
with long term neurological conditions suggests there is a need to review and develop an 
understanding of therapies that can target the functional underpinnings of multiple 
psychological problems. It may be advantageous for clinicians to develop a better 
understanding of working transdiagnostically with these features of long term neurological 
conditions using third wave therapies. An overall review of third wave therapies for 
neurological conditions thus seems timely.  
 
This review has two aims, to: (i) summarise and evaluate current treatment studies using third 
wave therapy approaches for long term neurological conditions; and (ii) consider the nature 
of the study, the quality of the evidence, the proposed transdiagnostic processes or factors 
targeted for intervention, the outcomes being measured, and treatment outcomes. 
 
METHOD 
The methodology and results followed PRISMA guidelines for reporting systematic reviews 
(Moher et al., 2010), using items 1-3, 6-12, 17-20 and 24-26 and a study flow diagram 
(Figure 1). Given the diversity of study types, a systematic review with qualitative synthesis 
of results was completed. PRISMA items not included were outside of the scope of the 
current review. 
 
Insert Figure 1 here 
 
Search strategy 
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PsycInfo, PubMed and Embase were searched using the following keyword terms. Within 
PsycInfo, PsycExtra and PsycTests were not searched. Table 1 summarises the search 
strategy. The search terms were checked to work in all three databases. No date restrictions 
were applied. The closing date of the search was December 2016.  
 
Insert Table 1 here. 
 
Study selection  
The database searches and study selection were undertaken by the lead author. Papers were 
broad screened by scanning the titles and abstracts, with reference to the eligibility criteria. 
When there was an indication of eligibility, the entire paper was retrieved for a full text 
review. A record was kept of the papers excluded. Due to the expected low yield of papers, a 
decision was made not to exclude research solely on the basis of poor methodological quality 
but to indicate the quality using a quality appraisal tool. The references of all selected studies 
were hand-searched for additional published reports and citations of unpublished studies and 
relevant review papers were also checked. Studies were included if they were believed to 
have met the following study characteristics (Population, Intervention, Comparatives, 
Outcomes, Timing and Setting).  
 
Populations 
Studies where participants were aged 18 years or older with a long-term neurological 
condition were included. For the purposes of the review, this included: progressive conditions 
such as MS, Parkinson’s disease and MND; intermittent disorders such as epilepsy; and 
sudden-onset conditions, such as TBI, ABI including stroke, and spinal cord injury. 
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Interventions 
The third wave therapy approaches included were ACT, CFT/CMT, and MBSR/MBCT. 
These approaches were considered pertinent to working therapeutically with common 
psychological factors associated with long term neurological conditions. The psychological 
intervention was required to be delivered through face-to-face meetings between client and 
therapist. Psychological therapy approaches conducted on an individual or group basis were 
included. The number of sessions was not limited, and we accepted psychological therapy 
interventions delivered in a single session.  
 
Comparators 
A comparison group was not required for inclusion, and study selection was not limited by 
Time or Setting.  
 
Outcomes 
Studies with pre- and post-intervention measures were included. No stipulations were made 
about types of outcome due to the nature of possible outcomes, to maximise the scope of the 
work. Particular attention will be made to measures of mood and psychological distress, and 
model-specific outcome measures to assess the core elements of a specific theoretical 
orientation. In the case of third wave therapies, this may be a measure of a transdiagnostic 
factor specific to the therapy being offered e.g. the process of acceptance in ACT. 
 
In addition, primary research such as case studies, case-series, quasi-experimental studies or 
randomised clinical trials (RCTs) were included. No exclusions were placed on study type, 
considering the emerging evidence base and the propensity for small-N designs. Non-English 
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language publications were excluded. Studies which focused solely on older adults were also 
excluded, due to the co-morbidity of ageing factors and focus on dementia-like symptoms. 
 
Data Extraction 
Included papers were exported into Endnote Web. A data extraction form, adapted from 
National Institute for Clinical Excellence (NICE) guidelines (2012), was used to summarise 
data, including: 1) study methods and setting; 2) population demographics, clinical and 
diagnostic details; 3) type, modality, frequency, duration of treatment and the transdiagnostic 
process or factors being targeted; 4) outcome measures; 5) and treatment outcomes. 
 
Quality assessment and risk of bias 
Three assessment tools have been used and the decision-making process for quality 
assessment was documented. In randomised studies, this was assessed using the Cochrane 
Collaboration’s tool for assessing risk of bias (Higgins et al., 2011). This tool provides a 
structure to evaluate the risk of bias across seven key domains, including: how a study selects 
participants; measures performance; blinds participants and investigators; explores attrition, 
and reports findings. Each domain for each study was allocated a ranking of “Low” (plausible 
bias unlikely to seriously alter the results), “Unclear” (plausible bias that raises some doubt 
about the results) or “High” risk of bias (plausible bias that seriously weakens confidence in 
the results). Global ratings were given through considering risk of bias across domains, with 
overall ratings of Low (low risk of bias for all key domains), Unclear (unclear risk of bias for 
one or more key domains), or High (high risk of bias for one or more key domains).  
 
The Newcastle-Ottawa Quality Assessment Scale (NOS; Wells et al., 1999) was used to 
appraise the quality of case-series, with and without control groups. This tool is endorsed by 
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the Cochrane Collaboration (Higgins et al., 2011). The scale identifies high quality choices 
with a star across three domains; a maximum of one star can be awarded for each of the four 
items in “selection”, each of the three items in “exposure/outcome” categories and a 
maximum of two stars for “comparability”. While the NOS manual does not provide overall 
quality descriptors based on the total number of stars, overall ratings will be determined for 
the studies, to allow for the consideration of outcomes. For the modified cohort scale (case 
series, no control group), one to two stars were considered Low quality, three to five stars as 
Moderate, and six to seven stars as High quality. For the modified case-control scale (case 
series, with control group), one to three stars were considered Low quality, four to six stars as 
Moderate, and seven to nine stars as High quality.  
 
For the single participant studies, the Single Case Experimental Design (SCED) scale was 
used (Tate et al., 2008). This is an 11-item rating scale of which 10 items are used to assess 
the methodological quality and use of statistical analysis in case studies. It has been found to 
have excellent inter-rater reliability for individual raters for the total score reported (overall 
intraclass correlation = 0.84; 95% confidence interval 0.78-0.95) (Tate et al., 2008). Quality 
descriptors were allocated for ratings to aid in the overall appraisal of quality, with scores of 
three or less considered Low quality, scores of four to six considered Moderate, and scores of 
seven to ten considered High quality. 
 
In addition, the third wave therapies will be overall appraised in relation to the current stage 
of the evidence base, using the Stage Model of Behavioural Therapies research (Rounsaville, 
Carroll, & Onken, 2001). This model articulates the progressive stages of the development 
and evaluation of behavioural treatments, from initial clinical innovation through efficacy 
research to effectiveness research (Rounsaville et al., 2001). Stage I consists of 
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pilot/feasibility testing, manual writing, training, and measure development for new 
treatments.  Stage II moves to RCTs to evaluate manualised and pilot-tested treatments, 
which have shown efficacy in earlier studies. Stage III consists of studies to evaluate 
transportability of treatments for which efficacy has been shown in at least two RCTs, with a 
focus on generalisability, implementation, and cost-effectiveness. Given the expected 
diversity of included study types for evolving interventions, this model can provide a useful 
basis for considering quality and risk of bias relative to the stage of treatment manual 
development and evaluation.  
 
RESULTS 
A range of study designs were employed, including RCTs (n = 7), a between-group repeated 
measures design (n = 1), case-series (n = 6) and single case-studies (n = 5). Studies were 
carried out across a number of countries, with just less than half (n = 9) of the reported 
studies undertaken in the UK. For the non-UK studies (n = 10), one was conducted in South 
Africa, one in India, two in Sweden, one in the US, two in Canada, one in Switzerland, one in 
Korea, and one in Belgium. Table 2 gives detailed study characteristics.  
 
Of the 486 participants included in the review, 167 (34.4%) were male and 319 (65.6%) were 
female.  The age of participants across studies ranged from 18 to 75 years. Mean ages of 
participants were similar across all studies. There were limited data overall regarding 
ethnicity, education and socio-economic status. Studies included a range of different clinical 
diagnoses and therapeutic modalities. Table 3 offers a summary of this.  
 
Insert Table 2 here. 
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Insert Table 3 here. 
 
Interventions were offered in a range of formats, including individual sessions only (n=8), 
group-based sessions only (n=7) , individual and sessions joint with a family member (n=1) 
or a mixture of individual and group sessions (n=3). The number of sessions attended by 
participants varied hugely across the studies, from one session or workshop (O’Neill & 
McMillan, 2012; Sheppard et al., 2010) to 24 sessions (Ashworth et al., 2011). Sessions were 
primarily offered on a weekly basis. Duration ranged from 30 minutes (O’Neill & McMillan, 
2012) to a full-day workshop (Ashworth et al., 2011). Of those studies that reported session 
duration, individual sessions (sole or in conjunction with groups) on average lasted an hour 
(n=12, M=1.2, SD=0.6); while group-based sessions (sole or in conjunction with individual 
work) were typically reported as longer (n= 8, M=3.75 hours, SD= 2.0).  
 
Across all studies, the rates of attrition ranged from 0% (Lundren et al., 2008) to 60% (Joo et 
al., 2010), excluding n=1 case studies. Overall, participant withdrawal was lower and better 
accounted for with the seven RCTs, with a mean attrition rate of 10.6% (SD=11.2). Reasons 
cited included moving, other commitments, scheduling issues, loss of interest, or disease-
related problems. 
 
Quality assessment and risk of bias 
The quality of the included studies was appraised independently for non-randomised research 
(including case-studies), and randomised research. They are discussed separately below.  
 
Quality assessment for randomised designs 
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The seven RCTs employed methods to reduce the potential for bias including random 
sequence allocation to intervention or control conditions, intention-to-treat analysis methods 
and blinding of assessors in analysing outcome measures. One RCT was assessed as Low risk 
of bias (Grossman et al., 2010), four as an Unclear risk (Bédard et al., 2015; Johansson et al., 
2012; Lundgren et al., 2008; Nordin & Rorsman, 2012) and two as at High (Lundgren et al., 
2006; Pickut et al., 2015). Some of the common criteria linked to an Unclear risk included a 
lack of information about allocation concealment and blinding of outcome assessors, while 
incomplete outcome data was linked to High risk of bias. All studies showed Low risk of bias 
in relation to selective reporting, meaning all pre-specified outcomes were reported. 
 
Quality assessment for non-randomised designs 
The potential for bias is known to be inherent to case studies, case series, and quasi-
experimental study studies due to sampling, selection and measurement biases. Applying the 
assigned quality descriptors for single-participant studies, three case studies were rated as 
Low quality (Ashworth, 2014; Ashworth et al., 2011; Gillanders et al., 2015) and two-case 
studies were rated as Moderate quality (Gillanders & Gillanders, 2014; Shields & 
Ownsworth, 2013). All included studies specified measures of target behaviours and reported 
raw data points, with the majority using statistical analysis. Methodological aspects not so 
well addressed included the use of A-B designs with pre- and post-evaluation measures only 
in four out of five studies (Ashworth, 2014; Ashworth et al., 2011; Gillanders & Gillanders, 
2014; Gillanders et al., 2015), and only one study (Shields & Ownsworth, 2013) employing 
the use of follow-up measures. None of the included case studies used multiple data points 
for baseline measures. In addition, there was an absence of discussion about inter-rater 
reliability for measures of target behaviours or independence of assessors.   
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Meanwhile, the case series and experimental study ranged in quality from 4 to 6 stars out of a 
maximum of 7 stars, using the modified NOS cohort scale (selection and outcome/exposure 
categories only); and 4 to 7 stars out of a maximum 9 for the modified case-control NOS 
scale (selection, comparability and outcome/exposure categories). Applying the quality 
descriptors to these star ratings, no studies were rated as Low quality; five studies were rated 
as Moderate quality (Bédard et al., 2003; Dewhurst et al., 2015; Joo et al., 2010; Kangas et 
al., 2015; Sheppard et al., 2010); and two studies were rated as High quality (Ashworth et al., 
2015; O’Neill & McMillan, 2012).  
 
Appraisal of third wave therapies 
The variable nature and quality of the third wave therapies may be better understood in terms 
of a Stage Model of Behavioural Therapies research (Rounsaville et al., 2001). According to 
this model, the reviewed research involving CFT is just within stage Ib of the model, with 
small-scale and non-randomised research. Taking the high-quality study by Ashworth and 
colleagues (2015), the feasibility of using CFT in brain injury has been demonstrated, with 
clinically significant patient improvements in mood and self-criticism over time and the 
consideration of effect sizes. What is currently lacking and needed for progression within the 
CFT literature is the use of a control group, larger sample sizes and randomisation to group. 
The reviewed ACT studies included more than two RCTs (Lundgren et al., 2006; 2008; 
Nordin & Rorsman, 2012), which meets criteria for stage III of the model. Likewise, the 
research utilising MBCT and MBSR has met the criteria for stage III (Bédard et al., 2015; 
Grossman et al., 2010; Johansson et al., 2012; Pickut et al., 2015). However, in both the ACT 
and MBCT/MBSR RCTs there were a majority of studies that had an unclear risk of bias. 
The Low risk of bias study by Grossman et al., (2010) addressees the previously covered 
issues with risk of bias and is a good example of a well-designed RCT. 
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Outcomes 
The effectiveness of third wave therapies was considered from treatment outcomes for mental 
health symptoms such as anxiety, depression and emotional distress; and model specific 
process outcomes, such as changes in acceptance, compassion and mindfulness. Table 2 
shows the range of self-report outcome measures administered. Within the third-wave therapy 
literature, the value of specific measures to assess transdiagnostic processes of change has 
begun to be recognised. The measures included in this review tap into transdiagnostic 
processes such as self-compassion, self-criticism, acceptance, psychological flexibility, 
thought defusion, values attainment and mindful awareness. 
 
Outcomes for randomised designs The randomised research tended to report statistical 
significance in terms of changes to group means from pre- to post-treatment, clinically 
significant change and effect sizes. A decrease in mental health symptoms such as anxiety, 
depression and emotional distress, were reported in three of the RCTs (Bédard et al., 2015; 
Grossman et al., 2010; Johansson et al., 2012). Changes on the Beck Depression Index (BDI) 
did not reach significance for Pickut et al. (2015) and this study was classed as poor quality.  
While Nordin and Rorsman (2012) observed a reduction in anxiety and depressive symptoms, 
this reduction was not as great for the group that received the ACT intervention compared to 
the Relaxation Training control group. Lundgren et al. (2006; 2008) did not report on anxiety 
and depression symptoms within their two studies.  
 
For the model-specific outcomes, there were reported statistically significant improvements 
in three of the RCTs relating to acceptance and psychological flexibility (Lundgren et al., 
2006; Nordin & Rorsman, 2012) and mindful awareness (Pickut et al., 2015).  Bédard et al. 
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(2015) found an increase in mindful awareness compared to controls but this did not meet 
statistical significance. They discuss the difficulties in capturing facets of mindfulness and 
the potential limitations of the scales measuring stable traits rather than states. Three out of 
seven of the RCTs did not use model-specific process measures (Grossman et al., 2010; 
Johansson et al., 2012; Lundgren et al., 2008), with two of these studies relating to 
mindfulness-based interventions. 
 
Outcomes for non-randomised designs Non-randomised studies tended to report 
statistical significance in terms of changes to group means from pre- to post-treatment; others 
considered clinically significant change and reliable change using a Reliable Change Index 
(RCI); and some offered effect sizes. A decrease in mental health symptoms such as anxiety, 
depression and emotional distress, were reported in 11 out of 12 of the non-randomised 
studies as statistically significant, while O’Neill and McMillan (2012) did not report 
intervention effects on distress. 
 
For the model-specific outcomes, there were reported statistically significant improvements 
in self-compassion and self-criticism (Ashworth, 2014; Ashworth et al., 2015); mindful 
awareness (Sheppard et al., 2010); thought suppression (Sheppard et al., 2010); and 
acceptance and psychological flexibility (Gillanders & Gillanders, 2014; Graham et al., 2015; 
Kangas et al., 2015). While Shields and Ownsworth (2013) found an increase in self-
compassion from low to moderate, this did not meet threshold for reliable change. Likewise, 
O’Neill and McMillan (2012) reported no significant treatment effect on self-compassion 
compared to relaxation controls. Both these studies hypothesise this is likely due to the 
shortness of the intervention (10 sessions and a 30-minute compassionate image induction 
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respectively). Three studies did not use model-specific process measures (Ashworth et al., 
2011; Dewhurst et al., 2015; Joo et al., 2010). 
 
DISCUSSION 
Overview 
The findings of the review indicate that using transdiagnostic third wave therapies shows 
some initial promise in addressing the emotional difficulties associated with long-term 
neurological conditions. A number of methodological and conceptual issues for the included 
studies were highlighted during the quality appraisal process and thought is given to how to 
progress third wave therapies through the Stage Model of Behavioural Therapies 
(Rounsaville et al., 2001). 
 
Considering included studies as a whole, 14 out of 16 studies demonstrated a statistically 
significant reduction in emotional distress, anxiety or depression. Of the 13 studies that used 
model-specific process measures, 10 found statistically significant improvements in 
transdiagnostic processes. Across all studies, there was considerable variability in 
methodological quality and statistical analysis. Specifically focusing on the High quality/Low 
risk of bias studies, clinically significant improvements were found for anxiety and 
depression (Ashworth et al., 2015; Grossman et al., 2010) and transdiagnostic factors such as 
self-criticism/self-compassion (Ashworth et al., 2015), with moderate to large effect sizes in 
these studies. The evidence for other transdiagnostic factors such as acceptance and 
mindfulness was not as strong, with studies appraised as either Unclear risk of bias or 
Moderate quality. Often, this was owing to a lack of information.  
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Overall, the findings of this review are consistent with those of recent systematic reviews and 
meta-analyses of third wave therapies more broadly, which comment on the methodological 
problems and risk of bias of the research (Hunot et al., 2013, Kahl, Winter, & Schweiger, 
2012; Ost, 2008; Ost, 2014).  For example, ACT has been the focus of most of the criticisms 
to third wave therapies, particularly its scarce empirical evidence and relatively small number 
of participants (Ruiz, 2012). There has been a strong increase in the number of published 
RCTs in recent years, and a number of meta-analysis have been produced (Ruiz, 2012; Ost, 
2014). Given the literature is in the early stages of development, perhaps it is better to think 
about what third wave therapies such as ACT can offer to complement and go beyond what is 
already offered by CBT. A particular strength is the emphasis on changing an individual’s 
relationship to events, thoughts or behaviours. In the case of ACT, the therapeutic target is to 
help patients experience difficult thoughts without struggling to change their content, and in 
parallel, to engage in behaviour consistent with their values. Positively, Ruiz (2012) found 
that ACT seemed to work through its proposed processes of change, such as increased 
cognitive defusion and decreased experiential avoidance.  This would suggest that using 
model-specific process measures is of value over-and-above symptom-only measures. The 
present review highlights that further consideration of processes of change are needed in 
empirical research, and to some degree this consideration is linked to the language used by 
studies and issues of conceptualisation.  
 
The authors of this review noted a discrepancy in the terms used within included studies and 
the wider literature, with the term ‘transdiagnostic process’ frequently not defined by studies 
and used interchangeably with other terms relating to transdiagnostic approaches. As 
discussed in the Introduction, this confusion can have implications for the processes a 
clinician or researcher is hoping to measure and change. Given that transdiagnostic 
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approaches are considered a paradigm shift and are still within their infancy, perhaps this 
suggests the literature needs further time to develop. This would enable the approaches to be 
tailored to working therapeutically with the emotional and neurobehavioral processes 
common to long term neurological conditions.  
 
Limitations 
Several limitations to this review should be noted. Firstly, while the published literature was 
searched systematically in several databases, trial registers were not searched for unpublished 
studies. This may unintentionally contribute to the “file drawer effect”. In addition, the grey 
literature was not searched. As Hunot et al. (2012) point out, there is a potential for some of 
the studies conducted most recently to have been excluded by these decisions. Secondly, non-
English language papers were excluded due to resource constraints. Despite this, papers from 
varied geographical locations were included, which goes someway to bolster the 
generalisability of the review conclusions. Thirdly, treatment fidelity was not assessed. In 
future versions of the review, it would be useful to extract information relating to adherence 
to the approaches such as independent ratings of randomly selected audio-visual recordings. 
 
Of note, there is some criticism in the literature towards the use of the Newcastle-Ottawa 
Scale. Stang (2010) comments that the growing use of the NOS as an apparently established 
“easy to use” quality score may be problematic, due to some items having uncertain validity. 
For example, the NOS gives the same score to studies that did independent or blind outcomes 
as those that utilised record linkage (outcome identification through database records). Stang 
(2010) highlights that this can lead to arbitrary results and far-reaching conclusions being 
drawn. In addition, low inter-rater reliability of the NOS between reviewers and authors has 
been suggested (Lo, Mertz, & Loeb, 2014). One possible explanation for the discrepancy is 
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that reviewers may not have all the information needed from the published article (Lo et al., 
2014). In this review, we did not contact study authors for additional information and 
therefore the NOS quality assessment of studies will be subject to the above limitations. 
 
Clinical implications 
Clinicians may want to consider using transdiagnostic approaches to address distress, as such 
approaches encourage patients to develop adaptive emotion regulation and mindful awareness 
skills (Shields et al., 2016). Using an approach such as ACT may be helpful in enabling 
adjustment to changed life circumstances (Dewhurst et al., 2013; Gillanders & Gillanders, 
2014) and CFT may be indicated when self-criticism is identified due to a discrepancy in 
self-concept (“old me, new me”) (Shields and Ownsworth, 2013). On one hand, there is 
promising evidence that favours a transdiagnostic approach to working with neurological 
conditions (Shields et al., 2016); while on the other hand studies exist that advocate disorder 
specific approaches (Waldron et al., 2013). Perhaps trying to reconcile these differences gives 
continued impetus for clinicians to be formulation-driven and to therapeutically consider both 
shared/transdiagnostic factors and unique factors related to specific neurological disorders, in 
planning and giving the most effective interventions. 
 
The length of an intervention may be a key consideration for clinicians. While approaches 
such as MBCT/MBSR are highly manualised and specify the number of sessions, other 
approaches such as CFT and ACT do not. This review has highlighted two CFT studies 
where the authors felt the interventions were too short in duration. A good example of session 
number and content can be accessed in the paper by Ashworth (2014), who gives a 
transparent and detailed account of the CFT intervention undertaken for the case study. 
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It is important that clinicians are also mindful of the questionnaires they use to measure 
treatment outcomes and processes of change. Not all the study questionnaires in this review 
have been validated for neurological populations and clinicians may need to carefully 
consider the validity of questionnaires they use. Self-report questionnaires about mood 
typically include items about being “slowed down” as well as changes in eating and sleeping. 
Such items are confounded by also measuring changes in functioning. The process measures 
for transdiagnostic factors are less likely to have the same construct validity issues, due to the 
different emphasis of items. For example, the Forms of Self-Criticism/Self-Attacking and 
Self-Reassuring Scale (Gilbert, Clark, Hempel, Miles, & Irons, 2004), or the Acceptance and 
Action Questionnaire-II (Bond et al., 2011). However, the language of the questionnaires 
may be too complicated for some clients who experience cognitive difficulties. Of note, 
Whiting, Deane, Ciarrochi, McLeod and Simpson (2015) have recently adapted and validated 
the AAQ-II for an ABI population (AAQ-ABI), with the questions featuring simplified 
language and a shorter 5-point rather than 7-point Likert scale. Further adaptations and 
validation studies may be required for other neurological populations.  
 
Research implications 
There are several implications for research in terms of strengthening the methodological 
quality and the use of validated model-specific outcome measures. In addition, 
recommendations are made for assessment of fidelity to treatment and the operationalisation 
of relevant terms in future studies. To progress the CFT literature, there is a need for larger 
sample sizes and the inclusion of a control group with randomised allocation, in order to 
consolidate a move from stage Ib to stage II of the Stage Model of Behavioural Therapies 
research (Rounsaville et al., 2001). Equally, more methodologically robust and rigorous trials 
are needed within the ACT and MBCT/MBSR literature, to address some of the known risks 
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of bias, and to aid generalisability, implementation and cost-effectiveness issues of stage III. 
Secondly, it is important that there is increased research into the reliability and validity of 
model-specific outcome measures with different neurological populations, through 
determining normative thresholds for commonly used measures. While fidelity to treatment 
was not assessed in this review, it was noted that not all studies discussed therapist adherence 
to the model for treatment. A future consideration should be on therapist adherence and 
competence measures. Future studies would also benefit from defining and operationalising 
relevant terms and constructs to give clarity to the reader. In addition, it would be 
advantageous for studies to draw together transdiagnostic processes and transdiagnostic 
approaches, so that the interventions and model-specific processes being evaluated clearly 
map onto the relevant transdiagnostic processes associated with long term neurological 
conditions. It is also worth being mindful of how theoretical developments within third-wave 
therapies can inform models of adjustment to neurological impairment, and in turn this can 
impact upon therapeutic targets and modalities at the clinical level.  
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